Conformational Trajectory of the Molecular Chameleon Grazoprevir From Formulation to Target‐Bound
Chemistry – A European Journal · 23.02.2026 · 32 (8)
DOI: 10.1002/chem.202502256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 18.12.2025. Verfasst von Lianne H E Wieske und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry for Life Sciences and the Center of Excellence for the Chemical Mechanisms of Life, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Sulfonamides, Quinoxalines, Macrocyclic Compounds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Howard Hughes Medical Institute, Vetenskapsrådet.
Abstract (Originalsprache)
Macrocycles represent a promising class of beyond‐rule‐of‐5 (bRo5) therapeutics, capable of targeting proteins traditionally considered undruggable by conventional small molecules. Macrocycles exhibit intrinsic flexibility and often display a “chameleon‐like” ability to adapt to their environment, thereby enhancing their oral bioavailability. Describing their structures and conformational changes is essential for advancing their development in the bRo5 space. In this study, we present the novel solid‐ and solution‐state structures of the macrocycle grazoprevir, determined using microcrystal electron diffraction (MicroED) and nuclear magnetic resonance (NMR) spectroscopy. A low‐energy core conformation was consistently identified throughout the conformational journey, from solid formulation to solvated states and upon complexation with the biological target, while the vinyl cyclopropyl sulfonamide side chain reoriented. The presence of a common core conformation (RMSD up to 0.273 Å) suggests that grazoprevir adopts a partial pre‐organized state, optimizing its suitability for target binding. In apolar environment, mimicking the cell membrane, intramolecular hydrogen bonding promoted the formation of compact conformations with reduced radii of gyration and solvent accessible 3D polar surface area, likely facilitating cell permeability. This work presents a comprehensive conformational trajectory of a macrocyclic chameleon and provides potential insights into understanding and characterizing cell permeability and chameleonicity of similar bRo5 therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry for Life Sciences and the Center of Excellence for the Chemical Mechanisms of Life, Uppsala University, Uppsala, Sweden.
- Department of Chemistry, University of California Riverside, Riverside, California, USA.
- Department of Biological Chemistry & Physiology, University of California Los Angeles, Los Angeles, California, USA.
- Howard Hughes Medical Institute, University of California Los Angeles, Los Angeles, California, USA.
ORCID-Profile: Emma Rova Danelius
Förderung
- NIGMS NIH HHS
- Howard Hughes Medical Institute
- Vetenskapsrådet
- U.S. Department of Defense
- National Institute of General Medical Sciences
Zitieren
APA
Wieske, L. H. E., Bu, G., Erdélyi, M., Kihlberg, J., Gonen, T., & Danelius, E. R. (2026). Conformational Trajectory of the Molecular Chameleon Grazoprevir From Formulation to Target‐Bound. Chemistry – A European Journal, 32(8). https://doi.org/10.1002/chem.202502256
Vancouver
Wieske LHE, Bu G, Erdélyi M, Kihlberg J, Gonen T, Danelius ER. Conformational Trajectory of the Molecular Chameleon Grazoprevir From Formulation to Target‐Bound. Chemistry – A European Journal. 2026;32(8). doi:10.1002/chem.202502256
BibTeX
@article{Wieske2026,
author = {Wieske, Lianne H E and Bu, Guanhong and Erdélyi, Máté and Kihlberg, Jan and Gonen, Tamir and Danelius, Emma Rova},
title = {Conformational Trajectory of the Molecular Chameleon Grazoprevir From Formulation to Target‐Bound},
journal = {Chemistry – A European Journal},
year = {2026},
volume = {32},
number = {8},
doi = {10.1002/chem.202502256}
}
EUVIMED